SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001214659-24-010680
Filing Date
2024-06-06
Accepted
2024-06-06 16:05:54
Documents
19

Document Format Files

Seq Description Document Type Size
1 s64240f1.htm   iXBRL F-1 693130
2 EXHIBIT 5.1 ex5_1.htm EX-5.1 67827
3 EXHIBIT 23.1 ex23_1.htm EX-23.1 5439
4 EXHIBIT 107 ex107.htm EX-FILING FEES 10302
9 GRAPHIC biodexa_logo.jpg GRAPHIC 13595
10 GRAPHIC forvismazars_logo.jpg GRAPHIC 16691
  Complete submission text file 0001214659-24-010680.txt   1191545

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bdrx-20240606.xsd EX-101.SCH 2924
6 XBRL DEFINITION FILE bdrx-20240606_def.xml EX-101.DEF 26578
7 XBRL LABEL FILE bdrx-20240606_lab.xml EX-101.LAB 36491
8 XBRL PRESENTATION FILE bdrx-20240606_pre.xml EX-101.PRE 25233
22 EXTRACTED XBRL INSTANCE DOCUMENT s64240f1_htm.xml XML 4467
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-279994 | Film No.: 241025034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)